UPCOMING SESSIONS in ET

Tue, Oct 27, 2026

5:00 – 6:00 AM Bangkok

Partnering With Your Care Team: Make the Most of Clinic Visits Van Thai Click Here To Register

UPCOMING SESSIONS in ET

Tue, Oct 27, 2026 · 5:00 – 6:00 AM Bangkok

Partnering With Your Care Team: Make the Most of Clinic Visits

Van Thai

Click Here To Register

View all sessions

Clinical Trials and Research

asco

Amyloidosis: Novel Treatments Could Improve Poor Outcomes

Mar 27, 2026

26-CCC-17870-ACC ENCASED HEART: SYSTEMIC AL AMYLOIDOSIS WITH EXTENSIVE PERICARDIAL CALCIFICATION

Read more

Mar 27, 2026

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Read more

amyloidosis

Mar 26, 2026

Amyloidosis

Read more

Mar 26, 2026

Head-to-head comparison of 11C-PiB and 18F-flutemetamol PET in transthyretin cardiac amyloidosis

Read more

Mar 24, 2026

Alnylam partners with Viz.ai, AHA on ATTR-CM diagnosis efforts

Read more

Mar 23, 2026

Rare case of young cardiac amyloidosis: difficult diagnostic pathway in routine clinical care

Read more

UCSF Clinical Trials

Mar 23, 2026

hATTR clinical trials at UCSF

Read more

amyloidosis

Mar 23, 2026

AL Amyloidosis clinical trials at UCSF

Read more

Mar 23, 2026

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

Read more

pubmed

Mar 18, 2026

Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: Part I-Technical Foundations, Techniques, and Endpoints

Read more

Newsletter

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion

Featured Trials